Delivery Order SPE2DX22D0019-SPE2D825FJS98
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,967.81 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 5, 2025, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $53,486.47 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with completion scheduled for September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,147.25 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued with no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply products. The contract was performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $12,185.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with an ultimate completion date of September 2, 2025. The delivery order was issued without set-aside designation through open competition and is classified as a child contract under a larger vehicle. AmerisourceBergen's Corporate Office, based in Conshohocken, Pennsylvania, serves as the place of performance...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,768.68 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 7, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The contract performs at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $29,029.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 5, 2025, with an ultimate completion date of July 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,788.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $4,974.48 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D825FJS98Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,903.08 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 30, 2025, with completion expected by October 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen's established capability to meet federal procurement requirements and serve critical customers including the Defense Health Agency and U.S. Coast Guard through flexible and comprehensive contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 9/30/25 |